Snapshot on drug-resistance rate and profiles in patients with chronic hepatitis B receiving nucleos(t)ide analogues in clinical practice

The rtL229 substitutions in the reverse transcriptase region of hepatitis B virus (HBV) polymerase are potentially associated with lamivudine resistance as a compensatory mutation

(2012) Dong Ji et al.   JOURNAL OF CLINICAL VIROLOGY

HBV DNA suppression and HBsAg clearance in HBeAg negative chronic hepatitis B patients on lamivudine therapy for over 5years

(2012) Massimo Fasano et al.   JOURNAL OF HEPATOLOGY

Characterization of drug-resistance mutations in HBV D-genotype chronically infected patients, naïve to antiviral drugs

(2011) R. Salpini et al.   ANTIVIRAL RESEARCH

Novel HBsAg markers tightly correlate with occult HBV infection and strongly affect HBsAg detection

(2011) Valentina Svicher et al.   ANTIVIRAL RESEARCH

Role of hepatitis B virus genetic barrier in drug-resistance and immune-escape development

(2011) Valentina Svicher et al.   DIGESTIVE AND LIVER DISEASE

Virological breakthrough and resistance in patients with chronic hepatitis B receiving nucleos(t)ide analogues in clinical practice

(2011) Chanunta Hongthanakorn et al.   HEPATOLOGY

Identification of hepatitis B virus rtS117F substitution as a compensatory mutation for rtM204I during lamivudine therapy

(2011) C.-L. Lin et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

MEGA5: Molecular Evolutionary Genetics Analysis Using Maximum Likelihood, Evolutionary Distance, and Maximum Parsimony Methods

(2011) K. Tamura et al.   MOLECULAR BIOLOGY AND EVOLUTION

Profile of HBV antiviral resistance mutations with distinct evolutionary pathways against nucleoside/nucleotide analogue treatment among Chinese chronic hepatitis B patients

(2010) Jing-Xian Yang et al.   ANTIVIRAL THERAPY

The natural history of chronic HBV infection and geographical differences

(2010) Yun-Fan Liaw et al.   ANTIVIRAL THERAPY

Lamivudine-resistance mutations can be selected even at very low levels of hepatitis B viraemia

(2010) Valentina Svicher et al.   DIGESTIVE AND LIVER DISEASE

Antiviral resistance and hepatitis B therapy

(2010) Marc G. Ghany et al.   HEPATOLOGY

Entecavir treatment for up to 5 years in patients with hepatitis B e antigen-positive chronic hepatitis B

(2010) Ting-Tsung Chang et al.   HEPATOLOGY

Antiviral effect of entecavir in chronic hepatitis B: Influence of prior exposure to nucleos(t)ide analogues

(2010) Jurriën G.P. Reijnders et al.   JOURNAL OF HEPATOLOGY

Hepatitis B Virus Resistance to Nucleos(t)ide Analogues

(2009) Fabien Zoulim et al.   GASTROENTEROLOGY

Long-term efficacy of tenofovir monotherapy for hepatitis B virus-monoinfected patients after failure of nucleoside/nucleotide analogues

(2009) Florian van Bömmel et al.   HEPATOLOGY

A Treatment Algorithm for the Management of Chronic Hepatitis B Virus Infection in the United States: 2008 Update

(2008) Emmet B. Keeffe et al.   Clinical Gastroenterology and Hepatology

2-Year GLOBE Trial Results: Telbivudine Is Superior to Lamivudine in Patients With Chronic Hepatitis B

(2008) Yun–Fan Liaw et al.   GASTROENTEROLOGY

Long-term efficacy and safety of adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B

(2008) Patrick Marcellin et al.   HEPATOLOGY

Hepatitis B virus escape mutants induced by antiviral therapy

(2008) J. Sheldon et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Impact of hepatitis B virus rtA181V/T mutants on hepatitis B treatment failure

(2008) Stéphanie Villet et al.   JOURNAL OF HEPATOLOGY

The profile of mutational clusters associated with lamivudine resistance can be constrained by HBV genotypes

(2008) Valentina Svicher et al.   JOURNAL OF HEPATOLOGY